home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  ANTIBACTERIAL & ANTIFUNGAL DRUG DISCOVERY & DEVELOPMENT SUMMIT  
  May 16, 2001

Biochemistry / Immunology

 
     
  Strategic Research Institute, Renaissance Amsterdam Hotel, Amsterdam EUROPE
June 28-29, 2001


SECTIONS:
Antibiotic Discovery Strategies & New Targets
Antibacterial Resistance Studies & Prevalence
Antibacterial Clinical Compounds
New Anti-Fungal Agents & Clinical CompoundsANTIBACTERIAL

KEYNOTE:
The Trouble With Gram-Negatives
David M Livermore, Ph.D
CENTRAL PUBLIC HEALTH LABORATORY

ANTIFUNGAL KEYNOTE & SECTION:
New Anti-Fungal Agents: Filling a Clinical Need
Frank C. Odds, Ph.D., FRCPath
UNIVERSITY OF ABERDEEN

FEATURING:
MERCK(Cancidas)
FUJISAWA(Micafungin)
SCHERING-PLOUGH(Posaconazole)


 
 
Organized by: Strategic Research Institute
Invited Speakers: PRESENTERS INCLUDE:
Eli Lilly Company
Procter & Gamble Pharmaceuticals
Institut Pasteur
Wyeth Ayerst Research
GlaxoSmithKline
The R.W. Johnson PRI
Cubist, Inc.
Ribotargets
 
Deadline for Abstracts: ALL SLOTS ARE FULL
 
Registration: Contact Mark Alexay, 212-967-0095 x251 or Email Malexay@srinstitute.com for show information/reg
E-mail: malexay@srinstitute.com
 
  Posted by:   Mark Alexay  
Host: 12.3.58.10
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.